Your browser doesn't support javascript.
loading
Human Metabotropic Glutamate Receptor 5 Antibodies Alter Receptor Levels and Behavior in Mice.
Maudes, Estibaliz; Mannara, Francesco; García-Serra, Anna; Radosevic, Marija; Mellado, Araceli; Serafim, Ana Beatriz; Planagumà, Jesús; Sabater, Lidia; Dalmau, Josep; Spatola, Marianna.
Affiliation
  • Maudes E; Neuroimmunology Program, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Mannara F; Neuroimmunology Program, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • García-Serra A; Neuroimmunology Program, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Radosevic M; Neuroimmunology Program, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Mellado A; Neuroimmunology Program, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Serafim AB; Neuroimmunology Program, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Planagumà J; Neuroimmunology Program, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Sabater L; Neuroimmunology Program, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Dalmau J; Neuroimmunology Program, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Spatola M; Department of Neurology, University of Pennsylvania, Philadelphia, PA.
Ann Neurol ; 92(1): 81-86, 2022 07.
Article in En | MEDLINE | ID: mdl-35373379
Ophelia syndrome or encephalitis with antibodies against the metabotropic glutamate receptor 5 (mGluR5) manifests with behavioral changes, memory deficits, and anxiety. To study the antibody pathogenicity, mice received continuous cerebroventricular infusion of patients' or controls' immunoglobulin G (IgG) for 14 days, followed by a 15-day washout. The effects on hippocampal mGluR5 clusters were determined by confocal microscopy. Animals infused with patients' IgG, but not controls' IgG, showed memory impairment, increased anxiety, and decreased neuronal surface mGluR5 clusters. After antibody clearance, both behavioral and molecular changes reversed to baseline conditions. These findings support the pathogenicity of these antibodies in anti-mGluR5 encephalitis. ANN NEUROL 2022;92:81-86.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Encephalitis / Receptor, Metabotropic Glutamate 5 Limits: Animals / Humans Language: En Journal: Ann Neurol Year: 2022 Type: Article Affiliation country: Spain

Full text: 1 Database: MEDLINE Main subject: Encephalitis / Receptor, Metabotropic Glutamate 5 Limits: Animals / Humans Language: En Journal: Ann Neurol Year: 2022 Type: Article Affiliation country: Spain